Evaluation of Sleep Quality in Head and Neck Cancer Patients Throughout Treatment Course
- Conditions
- Malignant Head and Neck Neoplasm
- Interventions
- Other: Survey Administration
- Registration Number
- NCT05108233
- Lead Sponsor
- Thomas Jefferson University
- Brief Summary
This study examines how head and neck cancer treatment affects quality of sleep over time and factors that contribute to sleep quality. Sleep plays a critical role in healing and quality of life, and recent studies investigating sleep disorders in head and neck cancer patients reveal sleep quality is a major determinant of post-treatment outcomes. Information from this study may help researchers better understand how treatment impacts sleep quality so that they can make changes that may help improve patient sleep quality.
- Detailed Description
PRIMARY OBJECTIVES:
I. To describe the five (5) components of sleep quality in head and neck patients under different stages of post-op treatment and different environment.
II. To evaluate the effect of surgery, treatment and environment on the five (5) components of sleep quality in head and neck cancer patients.
SECONDARY OBJECTIVES:
I. To evaluate the association between the five (5) components of sleep quality and comorbid obstructive sleep apnea (STOP-BANG and Epworth Sleeping Scale) and depression (Patient Health Questionnaire-2 \[PHQ-2\]), under different stages of post-op treatment and different environment.
II. To evaluate the association between Fitbit actigraphy data (i.e. the 5th component of sleep quality) and the first 4 components of sleep quality for inpatients.
III. To compare the inpatient versus the outpatient responses on sleep hygiene at different time points of measurement.
EXPLORATORY OBJECTIVE:
I. To assess whether survey results warrant additional counseling or patient education.
OUTLINE:
COHORT 1-TP1: Patients complete surveys over 20 minutes on post-op day 3 and on day of discharge (or within 1 week).
COHORT 1-TP2: Patients complete surveys over 15 minutes at all regularly scheduled follow-up appointments (approximately 1 month, 3 months, 6 months, 12 months).
COHORT 2: Patients complete surveys over 15 minutes once.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 150
- Males and females
- Adult at least 18 years old
- Capable of giving informed consent
- Diagnosed with head and neck cancer (previously untreated, any stage)
- Treatment plan involves surgery
- Willing to comply with all study procedures and be available for the duration of the study
- English-speaking
-
Non-English speaking
-
Pre-existing sleep disorder defined below:
- Obstructive sleep apnea
- Insomnia
- Narcolepsy
- Restless leg syndrome
- Rapid eye movement (REM) sleep behavior disorder
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Observational (survey) Survey Administration COHORT 1-TP1: Patients complete surveys over 20 minutes on post-op day 3 and on day of discharge (or within 1 week). COHORT 1-TP2: Patients complete surveys over 15 minutes at all regularly scheduled follow-up appointments (approximately 1 month, 3 months, 6 months, 12 months). COHORT 2: Patients complete surveys over 15 minutes once.
- Primary Outcome Measures
Name Time Method Per-patient average score on Richards-Campbell Sleep Questionnaire Up to study completion; approximately 12 months Barriers to sleep quality Up to study completion; approximately 12 months Time in bed Up to study completion; approximately 12 months The time difference between time to get into bed and time to get up, measured in minutes
Sleep latency Up to study completion; approximately 12 months How long it takes to sleep, measured in minutes.
Sleep maintenance latency Up to study completion; approximately 12 months How long it takes to fall back to sleep, measured in minutes.
Per-patient sum of scores on Epworth Sleepiness Scale Up to study completion; approximately 12 months Sleep hygiene Up to study completion; approximately 12 months Number of nighttime awakening Up to study completion; approximately 12 months Per-patient sum of positive responses on STOP-BANG Up to study completion; approximately 12 months Per-patient sum of scores on Patient Health Questionnaire-2 Up to study completion; approximately 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Thomas Jefferson University Hospital
🇺🇸Philadelphia, Pennsylvania, United States